Vimarsana
Biggest News Aggregation in the World

Life Sciences Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Sciences Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Sciences Fund Today - Breaking & Trending Today

CSPAN Question Time January 12, 2015 - Vimarsana News

CSPAN Question Time January 12, 2015

Interviews are available online. Here are some others you might like. Scott berg on woodrow wilson. And amity shlaes on calvin coolidge. Www. Cspan. Org you can watch them atwww. Cspan. Org. Here are a few of the comments we have recently received on the 114th congress. The thing that really needs to happen is going back to what the incoming majority said, they need to get back to regular order. If they go back impact of 13 bills it would take to fund the government, everybody can see who voted for it. To put what amendment up, and let the president passed it or veto it. I hope it is a more ma...

AbilityPharma closes €7 million round for metastatic pancreatic cancer drug ABTL0812 - Vimarsana News

AbilityPharma closes €7 million round for metastatic pancreatic cancer drug ABTL0812

AbilityPharma closes €7 million round to fully fund its international Phase 2b clinical trial with the antitumor drug ABTL0812 in pancreatic cancer patients. 

Source: asebio.com
AbilityPharma Raises €7M in Financing - Vimarsana News

AbilityPharma Raises €7M in Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments - Vimarsana News

Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments

Diana Hausman, M.D., Accomplished Oncologist and Drug Developer, Appointed Chief Medical Officer Kyle Rasbach, Ph.D., Pharm.D., Experienced Biotechnology Portfolio Manager, Appointed Chief Business...

API maker Fleming Laboratories raises Rs 110 cr from PE fund InvAscent - Vimarsana News

API maker Fleming Laboratories raises Rs 110 cr from PE fund InvAscent

Fleming is a backward integrated API manufacturer with global leadership in select muscle relaxant, anti-arthritis, and antihistamine APIs with two regulatory-approved manufacturing units. The company sells to customers in over 65 countries across Latin America, Europe, Asia, and MENA.